A hybrid emotion-focused exposure treatment for chronic pain: A feasibility study  by Linton, Steven J. & Fruzzetti, Alan E.
Scandinavian Journal of Pain 5 (2014) 151–158
Contents lists available at ScienceDirect
Scandinavian Journal of Pain
journa l homepage: www.Scandinav ianJourna lPa in .com
Clinical pain research
A hybrid emotion-focused exposure treatment for chronic pain:
A feasibility study
Steven J. Lintona,∗, Alan E. Fruzzettib
a Center for Health and Medical Psychology, Department of Law, Psychology, and Social Work, Örebro University, Sweden
b Department of Psychology, University of Nevada, Reno, USA
h i g h l i g h t s
• Exposure in-vivo is helpful, but not sufﬁcient for patients suffering chronic pain.
• We developed a hybrid by combining exposure with an emotion-focused approach.
• We tested the hybrid in a single-subject controlled design.
• Participants improved on key outcomes often to normal levels.
• The hybrid shows promise and should be further tested in RCTs.
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Background and aims: Exposure in vivo for patients with fear-related chronic pain has a strong theo-
retical base as well as empirical support. However, the treatment does not work for every patient and
overall the effect size is only moderate, underscoring the need for improved treatments. One possible
way forward might be to integrate an emotion regulation approach since emotions are potent during
exposure and because distressing emotions may both interfere with exposure procedures and patient
motivation to engage in exposure. To this end, we proposed to incorporate an emotion-regulation focus
into the standard exposure in vivo procedure, and delivered in the framework of achieving relevant per-
sonal goals. The aim of this study then was to test the feasibility of the method as well as to describe its
effects.
Method: We tested a hybrid treatment combining an emotion-regulation approach informed by Dialec-
tical Behaviour Therapy (DBT) with a traditional exposure protocol in a controlled, single-subject design
where each of the six participants served as its own control. In this design participants ﬁrst make rat-
ings to establish a baseline from which results during treatment and the ﬁve month follow-up may then
be compared. To achieve comparisons, participants completed diary booklets containing a variety of
standardized measures including pain catastrophizing, pain intensity, acceptance, and function.
Results: Compared to baseline, all subjects improved on key variables, including catastrophizing, accep-
tance, and negative affect, at both post treatment and follow up. For 5 of the 6 subjects considerable gains
were also made for pain intensity and physical function. Criteria were established for each measure to
help determine whether the improvements were clinically signiﬁcant. Five of the six participants had
consistent results showing clinically signiﬁcant improvements across all the measures. The sixth partic-
ipant had mixed results demonstrating improvements on several variables, but not on pain intensity or
function.
Conclusions: This emotion-regulation hybrid exposure intervention resulted in considerable improve-
ments for theparticipants. The results of this studyunderscore thepotential utilityof addressingemotions
in the treatment of chronic pain. Further, they support the idea that targeting emotional stimuli and using
emotion regulation skills in conjunction with usual exposure may be important for obtaining the best
results. Finally, we found that this treatment is feasible to provide and may be an important addition to
usual exposure. However, sincewedid not directly compare this hybrid treatmentwith other treatments,
additional research is needed before ﬁrm conclusions can be made.
DOI of refers to article: http://dx.doi.org/10.1016/j.sjpain.2014.05.005.
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Implications: Addressing emotional distress in the treatment of patients suffering chronic pain appears
to be quite relevant. Emotion regulation skills, employed togetherwith exposure in vivo, hold the promise
of being useful tools for achieving better results for patients suffering fear-related and emotionally dis-
tressing chronic pain.
© 2014 The Authors. Published by Elsevier B.V. All rights reserved.
1. Introduction
Chronic pain is a pervasive and difﬁcult problem to treat and
consequently exposure in vivo for pain-related fear of movement
has offered a much welcomed treatment with a clear target and a
strong theoretical base [1]. While this exposure-based treatment
provided a breakthrough and has gained considerable empirical
support, controlled trials nevertheless suggest that it has only a
moderateeffect [1,2].Hence,while exposure is a step forward,more
effective methods are clearly needed [1].
There are three salient problems that hamper exposure in vivo
for pain-related fear. First, there is a problem in identifying the
exact stimuli that provoke fear and are the targets for exposure
[3]. Standardprocedures assume fear ofmovement.However, there
may be a host of other triggers such as emotional states [4] or inter-
nal stimuli including the pain itself [2]. Thus, restricting exposure
only to movements may compromise its effectiveness. Second is
the issue of safety behaviors.While exposure requires considerable
effort from the patient, it also provokes intense fear and challenges
common sense ideas that provoking pain is dangerous. It is not sur-
prising then that exposure is often a least preferred treatment,with
dropout rates of 30–50% [1] which may propel safety behaviours.
The role of safety behaviours during exposure is hotly debated,
since they might reduce the effects of exposure [5]. However, skil-
ful reduction or titration of negative affect may actually allow the
person to participate in the exposure [6]. One way of framing the
issue is to cast it in amotivational context [7]. Thus,whenpresumed
“safety behaviours” serve to achieve a goal they may instead be a
valuable “coping” strategy [7]. Third, is the documented problem
of generalizing results to daily life, where relapse after usual expo-
sure procedures is common [8]. Improvements in these areas then
should enhance the results of exposure treatments for pain-related
fear and related problems.
One way to address these problems might be a hybrid treat-
ment that combines usual exposure with an emotion regulation
approach conducted in a goal pursuit context [9,10]. First, this
would allow consideration of stimuli other than movements like
emotions and pain. Indeed, chronic pain is clearly linked to emo-
tional processes such as catastrophic worry, anger, shame, and
depression [9]. Passionateemotionsmaygenerateunhelpful escape
or safety behaviours [11]. Rather than only avoiding movement
then, these patients may learn to avoid a variety of personally
relevant, emotional stimuli [4]. And like other forms of phobia,
this avoidance, which reduces negative affect in the short term,
paradoxically may increase it in the long term. Second, engage-
ment might be improved by providing support and skills to deal
with the intense negative emotion involved (e.g. fear). Develop-
ing personally relevant goals also would seem to be essential from
a motivational perspective [7]. Third, providing emotion regula-
tion skills should encourage and empower patients to engage in
exposure and continue until their personal goals are achieved [12].
Finally, tackling exposure from an emotion regulation angle might
open the door for generalization since personal goals would be
in focus rather than simply being able to do a certain movement
[7].
A hybrid treatment might be based on the available exposure
in vivo method combined with an emotion regulation approach
informed by procedures in Dialectical Behaviour Therapy (DBT)
since DBT highlights emotion regulation skills and incorporates
goal pursuit. Thus, integrating emotion focused DBT techniques
into the exposure in vivo treatment for pain related fear might be a
way to discover triggers and address the intense emotional states,
theavoidanceofnegativeaffect, and thecatastrophicworry socom-
mon in chronic pain. In fact, two studies have explored treatments
focusing on emotion [4,13]. While showing promise, both involved
pilot studies with treatments that were not fully developed and
more data is urgently needed.
The purpose of this paper is to test a hybrid treatment that com-
bines a DBT inspired, emotion-regulation focused, treatment with
standard exposure treatment as a proof of concept. We hypothe-
sized that targeting negative affect, pain, and movements would
result in a reduction of their threat value, thereby reducing their
potential as negative reinforcers. Therefore, we expected that this
treatment would reduce negative affect such as catastrophic worry
and enhance rehabilitation as seen in acceptance and activities of
daily living while not provoking average pain intensity ratings.
2. Method
2.1. Overview of the design
A replicated single-case AB design [14] was employed to test
the hypothesis that the DBT exposure therapy would reduce catas-
trophizing, negative emotions, and increase function, while not
exacerbating pain intensity. Repeated measures, for each partic-
ipant, were ﬁrst taken during the baseline phase (A), when no
treatment was provided. Subsequently, repeated measures were
taken during the treatment (B) phase so that a comparison could be
made. Thus, the baseline (A) serves the same function as a no treat-
ment control group and if changes during treatment occur relative
to thebaseline, it canbe assumed that this is related to the interven-
tion. Follow up data provides comparison for determining longer
term utility. Replication was achieved via additional participants
which strengthens the ﬁndings and increases generality.
2.2. Participants
Six volunteer patients participated in the study. Inclusion crite-
ria were: chronic low back pain (current episode >3mo), a high
level of catastrophic worry (Pain Catastrophizing Scale, >24), and
no red ﬂags, co-morbid medical problems, or other ongoing treat-
ments. Fifty-three patients applied to an advertisement in a local
newspaper and the ﬁrst 8 who fulﬁlled the screening criteria were
invited for a full assessment. Twowereexcluded (1= co-morbiddis-
ease (Parkinson’s disease); 1 =ongoingmedical treatment (physical
therapy)). A description of the 6participants is presented in Table 1.
We followed the Helsinki ethical guidelines and obtained informed
consent.
2.3. Assessment
Outcome and process variables were assessed via diaries and
standardized questionnaires. A booklet contained daily ratings,
questionnaires to be completed every third day aswell as question-
naires that were completed once during baseline, post treatment,
and at the ﬁve month follow up. Booklets were completed
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Table 1
An overview of the participants including the duration of the problem as well as of the baseline and treatment.
ID # Age Sex Pain problem Duration of pain problem Length of baseline (days) Length of treatment (sessions/h)
1 54 F Low back pain, shoulders and knees 15 years 11 9 sessions/11h
3 39 M Low back pain 25 years 11 10 sessions/15.3h
4 71 F Low back pain, knees 1.5 years 15 10 sessions/10.5h
5 55 F Low back pain, hips 19 years 9 10/11h
6 33 F Low back pain, 4 years 12 9/12h
8 57 F Low back pain, shoulders, arms 23 years 12 9/12
throughout the baseline, treatment, and during one week after
treatment and follow-up respectively and they were also used for
detailed chain analyses. For benchmarking purposes, levels con-
sidered to be clinically relevant [15] were determined from the
literature and are indicated for each measure.
2.3.1. Primary measures
A daily diary was used to capture pain while the other primary
variables were assessed every third day during the course of the
study.
Pain Catastrophizing Scale (PCS). This questionnaire has good
psychometric properties and assesses catastrophic thinking with
13 assertions that are rated on 0–4 Likert scales where higher
scores indicate higher levels of catastrophizing [16]. Scores over 20
indicate an increased risk for poor outcome including functional
impairment and is used as a cut-off [17].
Daily measure of pain. Pain intensity was rated on an item from
the Örebro Musculoskeletal Pain Screening Questionnaire: “How
much pain have you experienced today?” with a 0–10 Likert scale
anchored by “no pain” and “worst possible pain” [18]. Clinically
relevant outcome involves an improvement of at least 2 points and
in surgical settings levels of 4 or less are considered not in need of
more analgesics [15,19].
Chronic Pain Acceptance Questionnaire (CPAQ). The CPAQ meas-
ures the impact of negative affect on the participant since
acceptance of pain is a proxy for experiential avoidance with 20-
itemsansweredona0 (“never true”) to6 (“always true”) Likert scale
[20]. A score of 47.8 has been reported at pre-treatment for highly
disabled patients suffering chronic pain and a post treatment value
of 71.4, a 49% increase is considered a good improvement [20].
Quebec Back PainDisability Scale (QBPS).TheQBPSmeasures how
difﬁcult it is to perform 20 daily activities rated from 0 (not at all
difﬁcult) to 5 (impossible to do) andhas good reliability andvalidity
[21]. An established benchmark for improvement is a reduction of
15 points or more [21], while another is a score of 30 or below
which is related to improvements ranging from “much better” to
“completely well” [22].
2.3.2. Secondary measures
Tampa Scale for Kinesiophobia (TSK). The TSK consists of 17
assertions rated on a four-point Likert scale (1 = strongly disagree;
4 = strongly agree) and the Swedish version has good reliability and
validity [23]. A cut-off score of 39 has been recommended for expo-
sure treatment and individual scores at post-exposure range from
18 to 44 with an average of 27 [1].
Hospital Anxiety and Depression Scale (HADS). The HADS consists
of 14 statements divided into an anxiety (HAD-A) and a depression
subscale. The HADS has been shown to be reliable in a Swedish
sample [24]. Scores are interpreted as 8–10,mild; 11–15moderate;
and >15 severe levels of anxiety and depression respectively [25].
Adverse Effects. Possible events thatmight be harmful or adverse
were recorded in session notes and a list of possible events was
reviewed at regular meetings of the therapists.
2.4. Treatment
Thehybrid treatmentwasdevelopedby combining abasic expo-
sure in vivo approach [26,27]with a DBT informed approach [12]. A
manual was developed to guide therapists in conducting the treat-
ment. Sessions were held once or twice a week over 6–9 weeks
with a range of 9–12 sessions (see Table 1).
2.4.1. Content
The treatment was conducted in stages and Table 2 provides an
overview and examples of the content. The ﬁrst stage focused on
three things: dialectical validation of the patient’s experience (i.e.,
complete validation of his or her experience, but also dialectically
noticing that current “solutions” are not effective, and exploring
other emotions that she or he might have missed), helping the
patient to develop concrete personal goals, and chain analyses to
identify important stimuli that triggered pain as well as emotions.
Considerable time was spent validating the patient’s own personal
experiences and developing a working analysis (chain analyses) of
the problem. We examined, for example, how feelings, thoughts,
andbehaviourswere related to thepatient’s pain anddifﬁculties. As
Table 2
An overview of the content of the DBT inspired exposure treatment.
Stage Methods (examples) Focus
I. Analysis of emotions and pain • Validation
• Chain analysis
• Values & goals
Soothe emotions to promote emotional experiencing and regulation. Identify important
personal goals; connect treatment targets to goals, and get commitment to targets.
Identify relationships among pain, negative emotion, and other stimuli for exposure.
II. Developing skills • Dialectics
• Self-validation
• Emotion regulation/coping skills
Use dialectic opposites as an aid to increase ﬂexible problem-solving. Self-validation to
promote emotional experiencing and decrease emotional reactivity. Various emotion
regulation strategies also to promote experiencing emotions and prepare for exposure.
Provide acceptance and change skills for negative emotions, and acceptance skills for pain.
III. Exposure training • Exposure for emotionally
sensitive stimuli
• Exposure in vivo for avoided
movements
Exposure for emotionally sensitive stimuli in session and in behavioural experiments at
home. It particularly focused on worry, guilt and repetitive thoughts that triggered
negative affect. Exposure for movements was done in session and keyed on a hierarchy
developed with the patient using the PHODA. Generalization was done with homework
and the promotion of goal activities that included the movements, plus emotion
management.
IV. Maintenance • Identifying key elements
• Planning for ﬂare-ups
Patients identiﬁed the key elements to the improvements made. A tool kit was formed
consisting of regularly employed methods and others in reserve for ﬂare-ups.
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an illustration, some patients identiﬁed guilt and shame as potent
emotions.Wehelped themto identify situationswhere theseoccur,
for example letting apartner dohousehold chores rather thanbeing
able to doing them for one’s self. These were used in developing
targets and hierarchies for exposure. In addition, the Photographic
Series of Daily Activities (PHODA) was employed to help develop a
hierarchy of movements for exposure [1]. The idea of “dialectics”
was introduced and explored e.g. avoidance versus confrontation.
Finally, a key feature of Stage one was developing personal goals.
We spent time during each session to explore what each patient’s
valued activities were and what might constitute important, chal-
lenging, and exciting goals to achieve. A plan was made to pursue
these goals in steps that were clearly deﬁned. These were referred
to when designing exposure and the dialectical behavioural exper-
iments described below.
Stage two consisted of systematic skills development designed
to enhance emotional regulation and prepare the patient for the
upcoming exposure. We worked with patients to develop selected
emotion regulation skills designed toenhanceexposure [12,13]. For
example, disturbing thoughts and feeling were identiﬁed, labelled,
but not judged or acted upon. Another example is savouring where
patients practiced about 15min per day to enjoy the moment and
positively attend to i.e. “savor” them. Self-validation was also prac-
ticed as a way of soothing negative emotions. Diary records were
kept as one way of evaluating goal pursuit attainment.
Stage three consisted of the exposure training. This encom-
passed applying the emotion-regulation skills from Stage two to
both feared movements and emotionally sensitive stimuli. For
movements, the standard procedurewas usedwhere patientswere
asked to engage in feared movements according to the hierar-
chy but they also were encouraged to practice emotion regulation
strategies both in and out of the session. For both movements
and emotions, dialectical behavioural experiments were devel-
oped, where the patient would engage in an avoided activity or
emotion with the help of, if desired, an emotion regulation strategy
so as to achieve a personal goal. The experiments were developed
by identifying how the patient was currently responding to sensi-
tive emotional ormovement stimuli and then looking at alternative
responses e.g. doing the opposite. These experiments then were
designed so that patients would confront feelings, situations, and
movements i.e. a form of exposure. For instance, to expose for the
guilt of having a partner do one’s household chores, the experiment
involved doing exactly the opposite, i.e. doing a deﬁned chore even
though the partner “offers to help”. The results are recorded and
reﬂection used to see how the dialect worked and what might be
learned from this.
Stage four sought to identify key elements in the programme
that contributed to progress, as well as factors that increased risk
for ﬂare-ups. Thus each patient identiﬁed the main things he or she
believedwas a key to bringing about change and thatwould be vital
for long-term results. A plan was made for how these skills would
be used and how ﬂare-ups could be handled. Commitment to using
the skills learned and managing risks were then used to develop
generalization and maintenance plans.
2.4.2. Therapists
Three therapistsdelivered the therapyper themanual.One ther-
apist was a certiﬁed psychologist and psychotherapist while the
other two were students in their ﬁnal term of a clinical psychology
programme.
3. Results
The results are presented for the primary and secondary meas-
ures of outcome using descriptive statistics and visual graphics as
recommended by experts in the ﬁeld [14,28,29]. First, the individ-
ual results for each measure are presented. For two of the primary
measures, we show the diary ratings across baseline, treatment,
and follow-up. To concisely provide an overview of results for all
participants, we use ﬁgures showing the baseline, posttreatment
and followupvalues. For anoverviewof the results acrossmeasures
for each individual we provide a summary description. Finally, in
order to judge clinical relevance, we have employed the standards
described above.
Fig. 1 illustrates the diary ratings for each individual participant
over the course of the study on the variable of pain catastrophizing.
As seen in Fig. 1, there were substantial, and sometimes dramatic,
decreases in scores on the PCS from baseline to the end of treat-
ment. These improvements were maintained or improved upon at
follow-up for ﬁve of the six subjects, while one (#4) showed some
deterioration at follow up. All of the participants were well above
the cut-off score for “catastrophing” (>20) at the baseline and all
had a decrease to the cut-off (#4) or below it (#1, 3, 5, 6, 8) at the
follow-up.
Pain was rated daily throughout the study and our assumption
was that the exposure would not provoke pain intensity. Fig. 2
shows the daily diary pain ratings for each individual at baseline,
through treatment, and at the follow-up. The variability of the pain
ratings was relatively high. All of the participants enjoyed some
decreases over treatment, although occasional days of high inten-
sity ratings occurred. In terms of clinical signiﬁcance, four of the
participants (#s 1, 3, 5, 6) met the criteria as their follow up ratings
fell below the lower level of the baseline range, and these four par-
ticipants also met the criteria of at least a two point decrease from
baseline to follow-up (#s 1, 3, 5, 6). At follow up, ﬁve of the six
participants (not #6) had a rating of 2 which is less than the abso-
lute criteria set for a low level of pain intensity. Participant #6 had
an increasing baseline ranging from 5 to 9 that decreased during
treatment (with some days of high ratings) and a follow up rating
of 4. No individual participant had an increase in pain at follow-up
relative to the baseline.
A third primary outcomewas negative emotion and acceptance.
Weemployed theCPAQtocapture this variablewherehigher scores
indicate greater acceptance. Since the CPAQ is designed to be used
at intervals and also to provide an overview of results we present
the pre, post and follow-up values for each participant in Fig. 3.
The baseline values ranged between 29 and 47. Moreover, every
participant clearly had a higher score at post-treatment (range
67–114) relative to the baseline. Three of the participants contin-
ued to improve at follow-up (#1, 3, 8) while three maintained their
improvements (4, 5, 6). All of the participants had scores at follow-
up that exceeded 71, which was set a priori as a benchmark for
clinical improvement.
Function was a fourth primary variable and the results for the
QBPS scale, which measures dysfunction, are graphically depicted
in Fig. 4. Baseline levels ranged from 24 to 70. Three participants
had higher levels of dysfunction (>50) at baseline (#4, 5, 8), while
three had relatively low scores indicating lower levels of physical
dysfunction (#1, 3, 6). Despite the wide range, the level of dysfunc-
tion at post treatment was lower for all subjects compared to the
baseline and this result was maintained at the follow up for ﬁve of
the six subjects (not # 6). One benchmark was an improvement of
15 points or more [21], while another was a score of 30 or below
[22]. Three participants easily met the ﬁrst criteria at follow up (#s
4, 5, 8), while three did not (#s 1, 3, 6);while all subjects had a score
of 31 or less at follow up.
Two important secondary measures assessed emotions. First,
the TSK was used to assess fear beliefs and the mean score for
the baseline, post treatment and follow up for each participant is
shown in Fig. 5. Five of the six patients had scores above 39 which
is the cut-off recommended for offering exposure treatment [1]. All
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Fig. 1. Ratings (3-day) on the Pain Catastrophizing Scale during baseline, treatment, and follow-up for each participant.
participants enjoyed a decrease between baseline and the post test
and three continued to improve at follow up (#1, 3, 8). While all
had a score of 39 or less at follow-up, indicating a lower level of
fear beliefs, three were also clearly below the benchmark criteria
of a score of 28 (#s 5, 6, 8), and two were within three points of this
level (#s 1, 3, 4).
Second, the HADs instrument was used to monitor levels of
anxiety and depression. Figs. 6 and 7 show the results for each par-
ticipant from baseline to post treatment and follow up for anxiety
and depression respectively. The HADS-A shows that only two par-
ticipants had scores indicating moderate anxiety at the baseline.
Nevertheless, all participants had lower scores at post treatment as
compared to the baseline. The follow up shows that 5 of the 6 had
even lower scores as compared to post treatment. All participants
were under the benchmark of 8 points indicating no observable
problem with anxiety. Similarly, the HADS-D indicated that 2 of
the 6 participants had scores indicatingmoderate depression at the
baseline, but even here all subjects had a decrease in scores at post
treatment and three (#1, 3, and 8) continued to improve at follow
up. As with anxiety, all subjects were below the benchmark level
of 8 points at the end of the follow-up, indicating no observable
problem with depression.
3.1. Overview of effects
In order to obtain an overall picture of the results for each
individual on all of the measures, we summarize the results for
each participant across all of the measures, thus underscoring
the clinical result on an individual basis. Taken together, ﬁve of
the participants had relatively consistent results showing relevant
improvements across all the measures, although #4 had some-
what smaller improvements. The exception is subject 6 who had
improvements on several variables, but not on two important vari-
ables, pain and function.
3.2. Adverse events
No potentially adverse or harmful events were recorded during
therapy sessions, homework, or between sessions during the study.
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Fig. 2. Daily ratings of pain (0–10) over baseline, treatment, and at follow up for each participant.
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Fig. 3. Scores on the Chronic Pain Acceptance Questionnaire for each participant at
the baseline, post treatment and follow up. The dotted red line indicates the deﬁned
level of clinical signiﬁcance based on post treatment values from earlier treatment
results.
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Fig. 4. Mean scores on the Quebec Back Pain Disability Scale at baseline, post treat-
ment, and Follow up for each of the 6 participants. The dotted red line indicates that
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Fig. 7. Mean scores on the HADS-Depression scale over the course of the study.
While only two participants had moderately elevated scores at the start, all enjoyed
a decrease at post treatment and follow up relative to the baseline. The dotted line
indicates the norm below which depression is not considered to be problematic.
4. Discussion
As a proof of concept, our ﬁndings demonstrate the feasibility
of providing a hybrid treatment combining an emotion regula-
tion focused DBT approach with a standard exposure treatment for
patients suffering chronic pain and they highlight overlooked fac-
tors in exposure e.g. the role of personal goals, emotions, and skills.
All of the participants completed the treatment (no dropouts),
were engaged (attended all sessions; completed homework assign-
ments), and also experienced substantial improvements. As we
anticipated, negative affect as measured by acceptance and
catastrophic worry signiﬁcantly decreased and physical function
improved. Moreover, we noted a remarkable decrease in ratings of
pain given the hypothesis that we would simply not provoke more
pain. Since previous studies have had difﬁculty in lowering vari-
ables such as catastrophizing and pain intensity for patients with
chronic pain, these results are noteworthy and suggest that the
method is sufﬁciently promising to continue researching it.
Although there is variation from patient to patient, our results
demonstrate rather large improvements. Four of the participants
(#1, 3, 5, 8) had consistent and large improvement across vari-
ables, while two (#4, 6) had medium improvements. In particular,
participants enjoyed substantial improvements in catastrophizing,
acceptance, andpain intensitywhere PCS values decreased an aver-
age of 72%, pain intensity 51%, and acceptance more than doubled.
Function as measured by the QBPS also improved. However, three
participants (#1, 3, 6) had relatively low levels of physical dysfunc-
tion, as measured by the QBPS, at the baseline and these three also
had the smallest percentage of improvement, indicating a possible
basement effect. In addition, pain levels were rated at just 2 (0–10
scale) for ﬁve subjects and at 4 for the sixth. Our results also show
that the participants often meet predetermined criteria for clini-
cally signiﬁcant improvements, noteworthy since this is rare for
patients with chronic pain [30].
Comparing our results with two of the randomized trials of
exposure in vivo [31,32] also sheds light on the size of the improve-
ment. For pain, the present study demonstrates an average 51%
reduction from pre to follow-up whereas Leeuw et al. reports a 17%
and Linton et al. a 23% reduction. Similarly for the QBPS, the current
ﬁnding is an average improvement of 41% while Leeuw et al. show
a 26% and Linton et al. a 15% improvement. Finally, for the PCS, we
ﬁnd a71% reduction as compared to a 35% reduction for Leeuwet al.
and a 25% reduction for Linton et al. These results provide hope that
this hybrid treatment may produce larger effects than traditional
exposure, with further development and evaluation.
The present ﬁndings support the idea that negative emotions
play an important role in chronic pain and exposure treatment
for distressed patients. While our ﬁndings are in line with the
fear-avoidance model, they also suggest that actively dealing with
other negative emotions, in a goal-pursuit context, might be help-
ful clinically. These results also add fuel to the debate about
safety behaviours during exposure where judicious use of safety
behaviour is asserted to be helpful [6]. Perhaps this suggests a ﬁner
distinction can be made between successful management of nega-
tive emotion and safety behaviours per se since safety behaviours
provide more dysfunctional escape from situations and negative
emotion) The current ﬁndings support this view as well as the idea
that the goal context is important [7]. Indeed, this study highlights
that the function of avoidance and the context in which it occurs
are vital aspects [9] and require further exploration.
This study has some limitations that should be kept in mind
when interpreting the results and designing future studies. First,
wehave employed a single-subject designwhichprohibits drawing
conclusions about howwell this treatmentwould fair against usual
exposure in vivo since these were not directly compared. Second,
generalization is limited and there is a profound need to evaluate
158 S.J. Linton, A.E. Fruzzetti / Scandinavian Journal of Pain 5 (2014) 151–158
the treatment with other samples and in other settings. Future
research should therefore replicate this single-subject design or
consider employing randomized designs utilizing a larger sample.
Third, one might question introducing yet another “treatment” for
these patients. However, this treatment is not a new procedure,
but rather the integration of existing ones. We believe that this
particular combination has merit and therefore we report on its
utility. Finally, a longer follow-up would provide more information
concerning the durability of the effects.
In summary, this study has demonstrated that a hybrid treat-
ment combining an emotion regulation-focused DBT inspired
treatment with standard exposure for patients with chronic low
back pain resulted in considerable improvements. It is striking that
patients achieved clinically relevant improvements, often to “nor-
mal” ranges, on key outcome variables. The results suggest that
treatments focusing on emotion regulation are helpful. While this
approach shows promise, future research is direly needed to test
its effects in other settings.
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